2 Top Biotech Stocks Ready for a Bull Run

Investing in biotech stocks can be exciting, but also risky. For certain companies, a lot can ride on the potential success of new drugs, providing outsize gains or punishing losses for investors depending on the outcome of clinical trials.

For two companies in particular, tailwinds from the pandemic have provided a cash cushion that mitigates some of that risk for investors. Of course, future success will depend on post-pandemic execution, but each business has a plan and is ready for a bull run in 2022.

Image source: Getty Images.

Source Fool.com